Free Trial

Tenaya Therapeutics (TNYA) SEC Filings & 10K Form

Tenaya Therapeutics logo
$0.64 -0.05 (-7.14%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.64 +0.00 (+0.09%)
As of 03/28/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tenaya Therapeutics SEC Filings

DateFilerForm TypeView
03/10/2025
8:40 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
8:41 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
8:42 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
8:43 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
8:44 PM
Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:19 PM
Tenaya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
7:22 PM
Casdin Capital, LLC (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13D/A
03/07/2025
6:50 PM
COLUMN GROUP III, LP (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13D/A
03/07/2025
6:14 PM
GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:14 PM
COLUMN GROUP III GP, LP (Reporting)
COLUMN GROUP III, LP (Reporting)
COLUMN GROUP III-A, LP (Reporting)
Column Group Opportunity III GP, LP (Reporting)
Column Group Opportunity III, LP (Reporting)
TCG Opportunity III GP, LLC (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
9:52 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
03/04/2025
3:28 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:42 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
11:51 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G
02/07/2025
7:29 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:30 PM
Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
3:58 PM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/07/2025
3:41 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
01/28/2025
7:00 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:12 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
6:58 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
6:24 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:48 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
Form SC 13G/A
11/06/2024
3:20 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2024
7:35 PM
Burroughs Amy L. (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:37 PM
GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:38 PM
Lee June (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:39 PM
Parschauer Karah Herdman (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:40 PM
Srivastava Deepak (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:41 PM
Stehman-Breen Catherine (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:42 PM
Tenaya Therapeutics (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:43 PM
Tenaya Therapeutics (Issuer)
Walsh Jeffrey T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:26 AM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/19/2024
7:30 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:23 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
7:23 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:24 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:25 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:26 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

08/08/2024
3:24 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
3:02 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:10 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:09 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
3:58 PM
Tenaya Therapeutics (Filer)
Form ARS
04/17/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form DEF 14A
04/17/2024
3:17 PM
Tenaya Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:TNYA) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners